Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on January 30, 2014. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ANNUAL REAGENTS FOR TRANSFUSION MEDICINE

Closed
14-004917Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

about 23 hours ago

DEADLINE

in 21 days
NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is seeking a qualified vendor for a one-time purchase of FDA-approved antibiotics to be stockpiled for city staff and their dependents. This procurement is intended to ensure rapid availability of medication following exposure to Category A agents, specifically anthrax, plague, or tularemia. The required deliverables include 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate/Monohydrate (100mg/dose). The purchase must be completed within the city's fiscal year ending June 30, 2027, with a strict delivery requirement of four business days from the time of order to the facility at 1845 N Fair Oaks Ave, Pasadena, CA. Vendors must adhere to rigorous CDC and industry standards for storage and handling, including cold-chain requirements and the use of temperature-monitoring devices during transit. Full lot-level traceability from production to distribution is mandatory, and all products must be accurately labeled with lot numbers, expiration dates, and manufacturer details. Bidders must be registered in SAM.gov with a Unique Entity ID and provide a Pasadena Business License. The selection process is an informal solicitation requiring electronic pricing submission via the City's eProcurement Portal by October 28, 2026. Award eligibility is contingent upon meeting insurance requirements, agreeing to Net 30 payment terms, and complying with federal regulations including the Buy America Requirement and the Davis-Bacon Act.
Public Health Department

POSTED

5 days ago

DEADLINE

in 8 days
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0116
Solicitation SPE2DP-27-T-0116 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon flavored electrolyte oral rehydration powder, identified by NSN 6505016462692. The requirement is for two packages, with each package containing 100 packets of 21 grams each. Each prepared packet provides a specific electrolyte composition consisting of 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when mixed into 16.9 fl oz of solution. The item is an over-the-counter product with a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 19, 2026. The shipping terms are FOB Destination, with the final delivery point being the USNS CODY T-EPF-14. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, while marking must adhere to Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation is associated with NAICS code 424210 and incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and requirements for safeguarding covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in about 13 hours

General Info

Agency

N/A

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

9000 Rockville Pike, BETHESDA, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Notice updated

Response deadline changed from Feb 20, 2014 to Feb 10, 2014. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Malinda DehnerContract Specialist
Barbara TaylorContracting Officer

Full Description

Show more
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH), Clinical Center (CC) intends to award a one year fixed price purchase order to Ortho-Clinical Diagnostics, Inc., Raritan, NJ 08869-1424 for the acquisition of reagents used in patient and donor testing. The proposed vendor, Ortho Clinical Diagnostics Inc. (OCD), an affiliate company of Johnson & Johnson Health Care System Inc. is the only known manufacturer and trademark holder of the OCD reagents that must be used with the ORTHO ProVueTM instrumentation currently in place for blood testing at the National Institutes of Health, Transfusion Services Lab. The requested reagents are used for compatibility testing performed on the OCD instrument, the ORTHO ProVueTM. The reagents are required to perform type, screens and cross matches necessary for patient testing prior to transfusion. Without these reagents patients in the Clinical Center cannot receive the transfusions necessary for their treatment per protocols at the NIH. These items or its equivalent if an upgraded product need to be awarded on/or before February 20, 2014 to ensure continued antigen and antibody testing of blood products. The estimated schedule of supply is attached to this notice. The comprehensive system of instruments and consumables is necessary to produce a complete testing result. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. The government reserves the right to increase quantity, pursuant to FAR 52.217-6. The purchase order shall not exceed the simplified acquisition threshold. Questions or comments referencing this posting number may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Malinda Dehner, Contract Specialist, dehnerm@cc.nih.gov by the due date and time marked in this notice.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS